WuXi AppTec (300357.SZ) obtained approval for clinical trials of the eczema diagnostic patch 02.

; Wisdom Financial News App News, Wuhan Biological (300357.SZ) announced that the company recently obtained the "Drug Clinical Trial Approval Notice" (Notice No.: 2025LP01362, 2025LP01363, 2025LP01364) downloaded from the National Medical Products Administration's government service portal. The clinical trial application for the drug "Dermatitis Diagnostic Patch 02 Patch" (hereinafter referred to as "this product") submitted by the company has been approved.